This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2022 Aug;227(2):371.

doi: 10.1016/j.ajog.2022.03.058. Epub 2022 Apr 2.

Elective induction in low-risk nulliparous women at 39 weeks' gestation: is it worse changing obstetrical practices?

Manon Vouga¹, David Desseauve²

Affiliations

Affiliations

¹ Maternal-Fetal and Obstetrics Research Unit, Department of Women, Mother and Child, Lausanne University Hospital, 1011 Lausanne, Switzerland; Department of Gynecology and Obstetrics, Réseau Hospitalier Neuchâtelois, Neuchâtel, Switzerland. Electronic address: manon.vouga@chuv.ch.
² Maternal-Fetal and Obstetrics Research Unit, Department of Women, Mother and Child, Lausanne University Hospital, Lausanne, Switzerland.

PMID: 35381193
DOI: 10.1016/j.ajog.2022.03.058

Comment

Elective induction in low-risk nulliparous women at 39 weeks' gestation: is it worse changing obstetrical practices?

Manon Vouga et al. Am J Obstet Gynecol. 2022 Aug.

. 2022 Aug;227(2):371.

doi: 10.1016/j.ajog.2022.03.058. Epub 2022 Apr 2.

Authors

Manon Vouga¹, David Desseauve²

Affiliations

¹ Maternal-Fetal and Obstetrics Research Unit, Department of Women, Mother and Child, Lausanne University Hospital, 1011 Lausanne, Switzerland; Department of Gynecology and Obstetrics, Réseau Hospitalier Neuchâtelois, Neuchâtel, Switzerland. Electronic address: manon.vouga@chuv.ch.
² Maternal-Fetal and Obstetrics Research Unit, Department of Women, Mother and Child, Lausanne University Hospital, Lausanne, Switzerland.

PMID: 35381193
DOI: 10.1016/j.ajog.2022.03.058

No abstract available

PubMed Disclaimer

Comment in

Statistical significance and clinical utility.
Gilroy LC, Al-Kouatly HB, Mclaren RA Jr,. Gilroy LC, et al. Am J Obstet Gynecol. 2022 Aug;227(2):372. doi: 10.1016/j.ajog.2022.03.059. Epub 2022 Apr 2. Am J Obstet Gynecol. 2022. PMID: 35381192 No abstract available.

Comment on

Changes in obstetrical practices and pregnancy outcomes following the ARRIVE trial.
Gilroy LC, Al-Kouatly HB, Minkoff HL, McLaren RA Jr. Gilroy LC, et al. Am J Obstet Gynecol. 2022 May;226(5):716.e1-716.e12. doi: 10.1016/j.ajog.2022.02.003. Epub 2022 Feb 6. Am J Obstet Gynecol. 2022. PMID: 35139334 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources